Find premium market and industry reports

DocStore » GBI Research » Research Reports » Market and Industry Reports

Per Page: 15 25 50

«1...

Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

Leading business intelligence provider, GBI Research, has released its latest research report, entitled: “Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail”. The report provides insights into the liver cancer therapeutics market in the US, the top five European countries (the UK, Germany, France, Italy and Spain) and Japan, with market forecasts until 2018. It provides in-depth analysis of the major marketed products, as well as insights into the liver cancer therapeutics R&D pipeline. The report also gives in-depth analysis of the unmet needs, drivers and barriers that affect the markets in these countries. Additionally, it discusses the global pipeline for all the liver cancer molecules across various stages of development.
Opioids Market to 2018 - Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

Leading business intelligence provider GBI Research has released its latest research report, entitled “Opioids Market to 2018 - Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market”. The current opioids market is characterized by a very broad and highly diversified product portfolio. Patients experiencing moderate to severe pain for a range of underlying physiological reasons are virtually exclusively treated with opioid analgesics. As a result, most patient populations experiencing more severe levels of pain across most pain indications, with the exception of, for example, migraines, are heavily dominated by opioids. As a therapeutic drug class, opioids have virtually no competition from molecules with non-opioid receptor targets. However, although the competition is virtually exclusively limited to opioid compounds, the current environment within this therapeutic class is highly competitive and strongly diversified. The approved drugs are based on 16 different opioid compounds and are differentiated on a range of characteristics, which include dosage, route of administration and pharmacokinetic features, as well as increasingly on the basis of abuse-resistance technologies.
Spinal Surgery Devices Market to 2018 - New Entrants and Technological Advances to Intensify Competition in the Spinal Fusion Segment

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

GBI Research’s report, “Spinal Surgery Devices Market to 2018 - New Entrants and Technological Advances to Intensify Competition in the Spinal Fusion Segment” provides key data, information and analysis on the global spinal surgery devices market. The report outlines the market landscape and competitive landscape and gives information on market trends for the spinal fusion devices segment and the spinal non-fusion devices segment. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on market dynamics. The report also reviews the competitive landscape and analyzes in detail the pipeline products in each segment. In addition, it reviews the details of important M&A deals that have taken place in the global spinal surgery devices market.
Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

GBI Research, the leading business intelligence provider, has released its latest research report: “Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes”. The report examines how mHealth, which is the facilitation of health-related information through mobile-enabled technologies, has been applied by the pharmaceutical industry in drug development and by healthcare providers in the developed and emerging economies to improve healthcare services and treatment outcomes.
Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity”. The report provides an in-depth analysis on stem cell research and development in India, China, Japan, South-Korea and Singapore. The report market analysis and forecasts for CABG, LSCT, Type 1 DM, Type 2 DM, Hearticellgram, Cerecellgram, Cartistem and Cupistem. The report also provides information on trends and pipelines. In addition to this, the report covers market drivers and challenges for stem cell research market.
Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

GBI Research, the leading business intelligence provider, has released its latest research, “Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs”. The report provides a comprehensive overview of the generic drugs market in the US, the top five countries in the European Union (EU, covering the UK, France, Germany, Spain and Italy) and Japan. The report focuses on the detailed analysis of major strategies implemented by the top 10 generic companies in the generic drugs market along with company portfolios and strategic analysis. The report gives detail on the current landscape and changes that have structured the generic drugs market. The report also contains an impact analysis of the regulatory landscape in the major geographies pertaining to the generic drugs market. The report also provides in-depth analysis of the unmet needs, drivers and barriers that affect the global generics market.
OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

GBI Research, the leading business intelligence provider, has released its latest research, “OTC Pharmaceuticals and Self-medication in Seven Emerging Markets - Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth”, which provides insights into the up-and-coming trends of the Over the Counter (OTC) pharmaceutical market by analyzing the trends in population health, healthcare and self-care in seven emerging markets: China, India, Russia, Brazil, Mexico, Indonesia and Turkey.
Innovation in the Prefilled Syringe Market - Biologics and Autoinjection Devices Shaping Future R&D Trends

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

GBI Research, the leading business intelligence provider, has released its latest research, “Innovation in the Prefilled Syringe Market - Biologics and Autoinjection Devices Shaping Future R&D Trends”, which provides insights into possible future avenues of R&D in the prefilled syringe market. This includes an overview of problems and possible solutions, as well as discussion of how the devices have developed to date to address problems with contamination, safety, fragility and ease of use.
Ethylene Vinyl Acetate (EVA) Global Market to 2017 - Growth in the Asia-Pacific and North American Solar Panel Sectors to Drive Demand

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

GBI Research’s ‘Ethylene Vinyl Acetate (EVA) Global Market to 2017 - Growth in the Asia-Pacific and North American Solar Panel Sectors to Drive Demand‘ is an in-depth report on the global Ethylene Vinyl Acetate industry. The report navigates the reader through the global Ethylene Vinyl Acetate (EVA) market with detailed analysis and forecasts of the major economic and market trends affecting the Ethylene Vinyl Acetate demand in all the major regions of the world. It includes analysis and forecasts of Demand major regions and countries. It provides major drivers and restraints for Ethylene Vinyl Acetate demand in various regions. Ethylene vinyl acetate demand share analysis by End Use, Ethylene Vinyl Acetate (EVA) Price analysis for all five geographic regions. Regional competitive break up is also included in this comprehensive report. Overall, the report presents a comprehensive analysis of the global EVA market covering all the major parameters.
Caprolactam Global Market to 2020 - Growth driven by Rising Demand from Nylon Fiber and Resin and Films Applications in China

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

GBI Research’s ‘Caprolactam Global Market to 2020 - Growth driven by Rising Demand from Nylon Fiber and Resin and Films Applications in China’ is an in-depth report focusing on the demand side of the global caprolactam industry. The report provides the reader with detailed analysis and forecasts of the major economic and market trends affecting global caprolactam demand in all the major regions of the world. It also provides analysis and description of the major drivers and restraints affecting caprolactam demand in various regions. Global caprolactam demand is assessed in terms of end-user segments, price and competitive landscape, at both the regional and national level. Overall, the report presents a comprehensive analysis of the global caprolactam market, covering all the major parameters.
Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

GBI Research, the leading business intelligence provider, has released its latest research, “Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth”. The report provides insights into the rheumatology therapeutics market forecasts until 2018 and examines global treatment usage patterns for various rheumatology disorders. It also looks at the geographical distribution of the rheumatology disorders therapeutics market across key geographies (the US, the top five countries of Europe, and Japan) and provides insights into the R&D pipeline and promising future blockbusters until 2018. The report also profiles major biopharmaceutical companies in the segment and analyzes M&A activity and licensing agreements.
Power Management Integrated Circuits (IC) Market to 2016 - Demand for Increasing Functionality in Smartphones and Tablets, and Rise in Smart Grid Utilization to Drive Growth

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

The report provides key information and analysis on the opportunities of power management IC market. The report provides information on industry dynamics, key suppliers, and the sales revenue and sales volume of power management ICs. The report also provides forecasts for power management ICs based on product type, region and end-application until 2016. Market size forecasts until 2016 are provided for voltage regulators, controllers and converters. The application markets-IT/computers, communications, consumer electronics, industrial/medical and automotive/defense are also discussed. With the rising demand for multi-featured portable gadgets, the demand for power management ICs is increasing. The potential growth markets for power management ICs include electric vehicles, renewable energy and smart grid markets, LED lighting and energy harvesting.
Semiconductors in the Patient Monitoring Systems Market to 2016 - Growth Dependent on Increasing Microcontroller and Analog IC Usage in Neonatal and Remote Patient Monitors

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

The report provides key information and analysis on the market opportunities of semiconductors in patient monitoring systems. The report provides information on industry dynamics, key suppliers, and the sales revenue and sales volume of semiconductors in patient monitoring systems. The report also provides forecasts for semiconductors in patient monitoring systems based on product type, region and end-application until 2016. Market size forecasts until 2016 are provided for discrete semiconductors, ICs, sensors and optoelectronics. The application markets-fetal monitors, MEMs, neonatal monitors, multi-parameter patient monitoring, remote patient monitoring and blood pressure monitors for the semiconductors in patient monitoring systems are also discussed.
LED and LED Driver IC Markets to 2016 - Government Incentives and Subsidies Drive Growth in Asia-Pacific, While Demand for Energy Efficient Lighting Drives the Global Market

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

The report analyzes key information on market opportunities in the Light Emitting Diode (LED) and LED driver Integrated Circuit (IC) markets. The report provides information on industry dynamics, key suppliers, and the sales revenue and sales volume of LEDs and LED driver ICs. The report also provides forecasts for LEDs based on product type, region and end-application until 2016. Market size forecasts until 2016 are provided for organic and inorganic LEDs. The mobile appliance, automotive, lighting, and signs/displays application markets for LEDs are also discussed. With the rising demand for portable devices and efficient lighting solutions, the LED market will increase. The potential growth markets for LEDs and LED driver ICs include display applications.
Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy

$3,500.00

$3,500.00
From:GBI Research

Document Overview:

This report examines the roles of Key Opinion Leaders (KOLs) within the pharmaceutical industry now and in the future. It looks at the roles traditionally held by KOLs. It describes the consequences of the changing healthcare environment on how the industry identifies and works with new groups of key opinion leaders, examining three areas of particular importance for KOL management within the pharmaceutical industry today. Firstly, the report will investigate the emerging trend to externalize research and to establish productive relationships with academic laboratories and principal investigators. Secondly, it will analyze the landscape for the traditional KOL – the healthcare professional – detailing changes to Codes of Practice guiding the pharmaceutical industry’s interactions with these individuals, trends in KOL management, and issues of relevance to emerging markets. Finally, the report considers the role of patients and their advocates in providing insights that should drive drug discovery and development in the future.

Per Page: 15 25 50

«1...

Market and Industry Reports

DocStore Search:

DocStore » GBI Research » Research Reports » Market and Industry Reports